About ABL
ABL is a company based in Rockville (United States) founded in 1961 was acquired by Oxford BioMedica in September 2023. It operates as a Professional Services and Direct-to-Consumer (D2C). The company has 15 employees as of March 28, 2024. ABL offers products and services including Biomanufacturing, ELISA Kits, and Virus Manufacturing. ABL operates in a competitive market with competitors including KBI Biopharma, Aldevron, Kemwell Biopharma, Eurogentec and Ovagen, among others.
- Headquarter Rockville, United States
- Employees 15 as on 28 Mar, 2024
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Abl, Inc.
- Jurisdiction Hyderabad, Telangana, India
-
Annual Revenue
$947.96 K (USD)-15.52as on Mar 31, 2023
-
Net Profit
$176.62 K (USD)-48.25as on Mar 31, 2023
-
EBITDA
$499.99 K (USD)-24.13as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
OXB
& 1 more
-
Employee Count
15
as on Mar 28, 2024
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ABL
ABL offers a comprehensive portfolio of products and services, including Biomanufacturing, ELISA Kits, and Virus Manufacturing.
Biomanufacturing services are provided for vaccine development.
ELISA kits are offered for research purposes.
Virus manufacturing is conducted for therapeutic applications.
People of ABL
Unlock access to complete
Funding Insights of ABL
Detailed funding history for ABL
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in ABL
ABL has secured backing from 2 investors. Prominent investors backing the company include OXB and BioQual.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Contract research on infectious disease models is conducted.
|
Locked | Locked | Locked | |
|
Gene therapies for multiple diseases are developed via lentiviral systems.
|
Locked | Locked | Locked |
Investor details for ABL
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ABL
Investment portfolio details for ABL
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ABL
Detailed financials for ABL
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Abl Comparisons
Peer comparison for ABL
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ABL
ABL operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as KBI Biopharma, Aldevron, Kemwell Biopharma, Eurogentec and Ovagen, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of protein formulation, process & cell line development, and cGMP services
|
|
| Locked | Locked | Locked |
Developer and custom manufacturer of nucleic acids, proteins and antibodies for research, clinical and commercial applications
|
|
| Locked | Locked | Locked |
Integrated biologics development and manufacturing are provided as a CDMO.
|
|
| Locked | Locked | Locked |
Oligonucleotides, peptides, and antibodies are developed and manufactured by Eurogentec.
|
|
| Locked | Locked | Locked |
Provider of germ-free and specific pathogen free production of eggs for vaccine and antibody manufacturing services
|
|
| Locked | Locked | Locked |
Precision fermentation services for biopharma and food are provided.
|
Detailed competitors of ABL
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Abl
Complete news archive for ABL
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ABL
ABL was founded in 1961.
ABL is headquartered in Rockville, United States. It is registered at Rockville, Maryland, United States.
As of Mar 28, 2024, the latest employee count at ABL is 15.
Annual revenue of ABL is $947.96K as on Mar 31, 2023.
ABL, Inc. is involved in the development and manufacturing of vaccines and biotherapeutics. Services are provided in biomanufacturing, virus production, process development, and aseptic fill-finish. Solutions are offered for gene therapies, oncolytic vectors, immunotherapies, and viral vaccines. The company operates in the biotechnology sector, supporting preclinical and clinical development stages. Testing capabilities are also extended through biologics and quality control services. Partnerships with government entities are maintained to advance therapeutic solutions.
ABL's top competitors include KBI Biopharma, Aldevron and Ovagen.
ABL offers Biomanufacturing, ELISA Kits, and Virus Manufacturing.